121 related articles for article (PubMed ID: 3165611)
1. Post-antibiotic effect in Bacteroides fragilis group.
Siverhus DJ; Edmiston CE; Clausz JC; Goheen MP
Ann Clin Lab Sci; 1988; 18(4):326-36. PubMed ID: 3165611
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of cefotetan and Sch 34343 to beta-lactamases produced by strains of Bacteroides that hydrolyse cefoxitin or imipenem.
Andrew JH; Greenwood D
J Antimicrob Chemother; 1987 May; 19(5):591-5. PubMed ID: 3497146
[TBL] [Abstract][Full Text] [Related]
3. Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis group.
Goldstein EJ; Citron DM
J Clin Microbiol; 1988 Nov; 26(11):2361-6. PubMed ID: 3235664
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the post-antibiotic effect (PAE) induced by ceftizoxime, ceftriaxone, cefoxitin, ampicillin-sulbactam, and ticarcillin-clavulanate against selected isolates of Bacteroides fragilis and B. thetaiotaomicron.
Aldridge KE
Anaerobe; 2002 Dec; 8(6):295-9. PubMed ID: 16887672
[TBL] [Abstract][Full Text] [Related]
5. National survey on the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004.
Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Golan Y; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Yu V; Rihs J; Gorbach SL
Antimicrob Agents Chemother; 2007 May; 51(5):1649-55. PubMed ID: 17283189
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of antimicrobial activity of amoxicillin/clavulanic acid and metronidazole against beta-lactamase-producing Bacteroides fragilis group.
García-Rodríguez JA; García Sánchez JE; Trujillano I; Muñoz-Bellido JL
J Chemother; 1990 Feb; 2(1):11-6. PubMed ID: 2332779
[TBL] [Abstract][Full Text] [Related]
8. Inducible metronidazole resistance in nim-positive and nim-negative bacteroides fragilis group strains after several passages metronidazole containing columbia agar plates.
Schaumann R; Petzold S; Fille M; Rodloff AC
Infection; 2005 Oct; 33(5-6):368-72. PubMed ID: 16258869
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers.
Turgeon P; Turgeon V; Gourdeau M; Dubois J; Lamothe F
Antimicrob Agents Chemother; 1994 Oct; 38(10):2276-9. PubMed ID: 7840557
[TBL] [Abstract][Full Text] [Related]
10. [Comparative effect of apalcillin and other beta-lactam antibiotics against the Bacteroides fragilis group].
Dusart G; Simeon de Buochberg M; Zuccarelli M; Attisso MA; Willemin C
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):523-7. PubMed ID: 2797878
[TBL] [Abstract][Full Text] [Related]
11. [Activity of cefotetan against anaerobic bacteria].
Sedallian A
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):643-4. PubMed ID: 2877431
[TBL] [Abstract][Full Text] [Related]
12. In vitro antibacterial activity of cefotetan against Bacteroides fragilis group clinical isolates.
Menozzi M; Avanzini P; Lecchini R; Bigi M; Chezzi C
Chemioterapia; 1987 Jun; 6(2 Suppl):88-91. PubMed ID: 3509541
[No Abstract] [Full Text] [Related]
13. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
[TBL] [Abstract][Full Text] [Related]
14. [Susceptibility of the Bacteroides fragilis group to 10 antibiotics. Results of 4 laboratories in Austria].
Mittermayer H; Rotter M; Riezinger F; Thiel W; Stanek G
Zentralbl Bakteriol Mikrobiol Hyg A; 1986 Nov; 262(4):500-11. PubMed ID: 3799095
[TBL] [Abstract][Full Text] [Related]
15. Differences in the in vitro inhibitory and bactericidal activity of ceftizoxime, cefoxitin, cefotetan, and penicillin G against Bacteroides fragilis group isolates. Comparison of time-kill kinetic studies with MIC values.
Aldridge KE; Weeks LS; Stratton CW; Sanders CV
Diagn Microbiol Infect Dis; 1990; 13(4):311-6. PubMed ID: 2076592
[TBL] [Abstract][Full Text] [Related]
16. [In vitro effects of cefotetan on anaerobic bacteria of the genus Bacteroides fragilis group, in comparison with 8 antibiotics].
Trevisan R; Proietti A; Pitzus E
G Ital Chemioter; 1985; 32(2):367-70. PubMed ID: 3869115
[No Abstract] [Full Text] [Related]
17. In vitro activity of two beta-lactam antibiotics against strains of the Bacteroides fragilis group isolated from humans and from Callithrix penicillata marmosets.
Avila-Campos MJ; de Carvalho MA; Veiga-Damasceno CA; Osório-Cisalpino E
Rev Latinoam Microbiol; 1994; 36(3):159-62. PubMed ID: 7709091
[TBL] [Abstract][Full Text] [Related]
18. The antibiotic sensitivity of the Bacteroides fragilis group in the United Kingdom.
Fox AR; Phillips I
J Antimicrob Chemother; 1987 Oct; 20(4):477-88. PubMed ID: 3680088
[TBL] [Abstract][Full Text] [Related]
19. National survey on the susceptibility of Bacteroides Fragilis Group: report and analysis of trends for 1997-2000.
Snydman DR; Jacobus NV; McDermott LA; Ruthazer R; Goldstein EJ; Finegold SM; Harrell LJ; Hecht DW; Jenkins SG; Pierson C; Venezia R; Rihs J; Gorbach SL
Clin Infect Dis; 2002 Sep; 35(Suppl 1):S126-34. PubMed ID: 12173121
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group.
Bremmelgaard A; Jansen JE; Justesen T; Gottschau A
APMIS; 1993 Sep; 101(9):727-31. PubMed ID: 8240792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
